Publication | Closed Access
LBA6 KRYSTAL-1: Adagrasib (MRTX849) as monotherapy or combined with cetuximab (Cetux) in patients (Pts) with colorectal cancer (CRC) harboring a KRASG12C mutation
74
Citations
0
References
2021
Year
Gastrointestinal OncologyLba6 Krystal-1MedicineImmunologyColorectal CancerPathologyImmune Checkpoint InhibitorMolecular OncologyCancer TreatmentCancer GeneticsOncologyCancer ResearchKrasg12c Mutation
No additional data available for this publication yet. Check back later!